Business Description
Pila Pharma AB
ISIN : SE0015988274
Compare
Compare
Traded in other countries / regions
PILA.Sweden5KC.Germany IPO Date
2021-08-05Description
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.7 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 8.31 | |||||
| Beneish M-Score | -5.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 1.2 | |||||
| 3-Year EPS without NRI Growth Rate | -13.1 | |||||
| 3-Year FCF Growth Rate | -22.9 | |||||
| 3-Year Book Growth Rate | 9.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.37 | |||||
| 9-Day RSI | 36.97 | |||||
| 14-Day RSI | 38.67 | |||||
| 6-1 Month Momentum % | 75.11 | |||||
| 12-1 Month Momentum % | 225.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 1.47 | |||||
| Cash Ratio | 1.33 | |||||
| Days Sales Outstanding | 12.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -436.98 | |||||
| Net Margin % | -678.74 | |||||
| FCF Margin % | -324.62 | |||||
| ROE % | -316.09 | |||||
| ROA % | -194.32 | |||||
| ROIC % | -174.72 | |||||
| ROCE % | -314.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 63.89 | |||||
| PB Ratio | 42.59 | |||||
| EV-to-EBIT | -11.26 | |||||
| EV-to-EBITDA | -12.64 | |||||
| EV-to-Revenue | 76.11 | |||||
| EV-to-FCF | -25.18 | |||||
| Earnings Yield (Greenblatt) % | -8.89 | |||||
| FCF Yield % | -4.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pila Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.13 | ||
| EPS (TTM) (€) | -0.042 | ||
| Beta | 1.47 | ||
| Volatility % | 147.27 | ||
| 14-Day RSI | 38.67 | ||
| 14-Day ATR (€) | 0.026613 | ||
| 20-Day SMA (€) | 0.3686 | ||
| 12-1 Month Momentum % | 225.1 | ||
| 52-Week Range (€) | 0.084 - 0.652 | ||
| Shares Outstanding (Mil) | 27.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pila Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pila Pharma AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pila Pharma AB Frequently Asked Questions
What is Pila Pharma AB(FRA:5KC)'s stock price today?
The current price of FRA:5KC is €0.33. The 52 week high of FRA:5KC is €0.65 and 52 week low is €0.08.
When is next earnings date of Pila Pharma AB(FRA:5KC)?
The next earnings date of Pila Pharma AB(FRA:5KC) is 2025-02-27.
Does Pila Pharma AB(FRA:5KC) pay dividends? If so, how much?
Pila Pharma AB(FRA:5KC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers